Immunstimulating lipid formulation

Details Immunstimulating lipid formulation Immunstimulating lipid formulation

2006-10-31

2006-10-31

Kishore, Gollamudi S. (Department: 1615)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C424S204100, C424S206100, C424S215100, C424S236100, C514S937000

Reexamination Certificate

active

07128909

ABSTRACT:
A pharmaceutical formulation for parenteral or mucosal administration of antigens and/or vaccines to humans and animals, comprising monoglyceride preparations having at least 80% monoglyceride content and where the acyl group contains from 6 to 24 carbon atoms, together with fatty acids where the number of carbon atoms may be varied between 4 and 22.

REFERENCES:
patent: 4073743 (1978-02-01), Midler et al.
patent: 4446165 (1984-05-01), Roberts
patent: 4997851 (1991-03-01), Isaacs
patent: 5256641 (1993-10-01), Yatvin et al.
patent: 5352450 (1994-10-01), Koga
patent: 5716637 (1998-02-01), Amselem
patent: 5730989 (1998-03-01), Wright
patent: 5739118 (1998-04-01), Carrano
patent: 0 544 612 (1993-06-01), None
patent: 1374325 (1974-11-01), None
patent: WO93 06921 (1993-04-01), None
patent: WO95 22989 (1995-08-01), None
Tengamnuay et al., Pharmaceutical Research. 7:127-133 (1990).

Affiliated with

Also associated with

Rating

Immunstimulating lipid formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunstimulating lipid formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunstimulating lipid formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3698255